Hap Trading, LLC Solid Biosciences Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $7,138 - $20,584	-16,600 Reduced 62.17%	10,100 $1,000
Q2 2021 Aug 11, 2021	SELL	$3.49 - $5.51 $20,242 - $31,958	-5,800 Reduced 17.85%	26,700 $1,000
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $77,865 - $155,440	14,500 Added 80.56%	32,500 $31,000
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $55,440 - $140,220	18,000 New	18,000 $55,000
Q1 2020 May 08, 2020	SELL	$2.31 - $4.43 $64,218 - $123,153	-27,800 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.82 - $12.9 $78,396 - $358,620	27,800 New	27,800 $2,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.